Search Results - "Aluwini, S."

Refine Results
  1. 1
  2. 2

    Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial by Janssen, J, Staal, F H E, Brouwer, C L, Langendijk, J A, de Jong, I J, van Moorselaar, R J A, Schuit, E, Verzijlbergen, J F, Smeenk, R J, Aluwini, S

    Published in BMC cancer (02-05-2022)
    “…More than 60% of oligo-recurrent prostate cancer (PCa) patients treated with metastasis-directed radiotherapy (MDRT) develop biochemical recurrence within…”
    Get full text
    Journal Article
  3. 3

    Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy by Janssen, J., Staal, F.H.E., Langendijk, J.A., Both, S., Brouwer, C.L., Aluwini, S.

    “…•Pelvic lymph node intrafraction motion was limited to 3 mm in 97–100 % of fractions.•A 3-mm PTV margin was associated with a high mean lesion inclusiveness…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20